𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells

✍ Scribed by Xiao-Li Li; Chong-Zhi Wang; Sangeeta R. Mehendale; Shi Sun; Qi Wang; Chun-Su Yuan

Publisher
Springer
Year
2009
Tongue
English
Weight
609 KB
Volume
64
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disulfiram-mediated inhibition of NF-κB
Disulfiram-mediated inhibition of NF-κB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines
✍ Weiguang Wang; Howard L. McLeod; James Cassidy 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 732 KB

## Abstract 5‐Fluorouracil (5‐FU) is the major chemotherapeutic component for colorectal cancer (CRC) and other types of solid tumours. Resistance of cancer cells to 5‐FU is considered the major obstacle for successful chemotherapy. NF‐κB is a transcription factor. Cancer cells with high NF‐κB nucl

The effects of γ-interferon combined wit
The effects of γ-interferon combined with 5-fluorouracil or 5-fluoro-2′-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines
✍ Ingrid W. H. M. Maas; Epie Boven; Herbert M. Pinedo; Hennie M. M. Schlüper; Hidd 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 840 KB

Gamma-Interferon (IFN-y) and the antimetabolites 5fluorouracil(5-FU) and 5-fluoro-2'-deoxyuridine (FUdR) were investigated as individual agents and in combination for their in vitro antiproliferative capacity and for their effect on the expression of HLA class-I antigen, carcinoembryonic antigen (CE

Curcumin enhances the effects of 5-fluor
Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R
✍ Bhaumik B. Patel; Radha Sengupta; Sadia Qazi; Hetal Vachhani; Yingjie Yu; Arun K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 297 KB 👁 1 views

## Abstract Curcumin (diferuloylmethane), which has been shown to inhibit growth of transformed cells, has no discernible toxicity and achieves high levels in colonic mucosa. 5‐fluorouracil (5‐FU) or 5‐FU plus oxaliplatin (FOLFOX) remains the backbone of colorectal cancer chemotherapeutics, but wit